Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2005-10-18
2005-10-18
Allen, Marianne P. (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C702S020000
Reexamination Certificate
active
06957148
ABSTRACT:
The use of antisense oligodeoxyribonucleotides (ODNs) to inhibit translation of mRNAs promises to be an important means of controlling gene expression and disease processes. ODNs are about 20 nucleotides long, so hundreds of possible targets are available in a given mRNA. An elusive goal has been to efficiently predict the best in vivo antisense target without having to study a large pool of possible ODN sequences for each mRNA. It would be a breakthrough if ODN selection could be accurately guided by the application of sequence specific parameters to an mRNA sequence. The selection of the best ODN sequence is complicated since cellular uptake, conditions at the mRNA target site, non-sequence-specific effects, sequence redundancy, and mRNA secondary structures are difficult to predict. Thermodynamic parameters for nearest-neighbor (dimer) duplex stabilities, from in vitro studies, have not been adequate predictors of in vivo hybridization. The methodology of this application shows that it is possible to obtain parameters for in vivo motifs, which are defined as combinations of next-nearest-neighbors, that are correlated with efficient antisense targeting. These parameters can be used to identify mRNA sequences that are binding sites for effective antisense ODNs. Next-nearest-neighbor nucleotide parameters can be derived directly from cell culture inhibition data so that in vivo conditions are taken into account.
REFERENCES:
patent: 5856103 (1999-01-01), Gray et al.
patent: 6183966 (2001-02-01), Gray et al.
patent: WO 94/23755 (1994-10-01), None
patent: WO 95/02069 (1995-01-01), None
Hidetoshi Arima, et al., “Design of Potent Phosphorothioate Antisense Oligonucleotides Directed to Human Interleukin 10 Gene Product and Their Evaluation of Antisense Activity in U937 Cells”, Pharmaceutical Research (New York), vol. 16, (No. 8), pp. 1163-1171, 1999.
S.T. Crooke, “Basic Priniciples of Antisense Therapeutics”, Antisense Research and Applications, CRC Press, GB, pp. 1-50, 1998.
Wen-Chun Hung, et al, “Antisense Oligodeoxynucleotides Targeted Against Different Regions of CyclinD1 mRNA May Exert Different Inhibitory Effects on Cell Growth and Gene Expression”, Biochemical and Biophysical Research Communications, vol. 220,(No. 3), pp. 719-723, 1996.
Sergey V. Ivanov, et al., “Down-Regulation of Transmembrance Carbonic Anhydrases in Renal Cell Carcinoma Cell Lines by Wild-Type Von Hippel-Lindau Transgenes”, Proceedings of the National Academy of Science of USA, vol. 95, pp. 12596-12601, 1998.
Song Hai-Feng, et al., “Application of Secondary Structure Prediction in Antisense Drug Design Targeting Protein Kinase C-α mRNA and QSAR Analysis”, Acta Pharmacologica Sinica, vol. 21 (No. 1), pp. 80-86, 2000.
Masato Mitsuhashi, “Strategy for Designing Specific Antisense Oligonucleotide Sequences”, Journal of Gastroenterology, vol. 32, (No. 2), pp. 282-287, 1997.
Alexey V. Laptev, et al., “Specific Inhibition of Expression of a Human Collagen Gene (COL1A1) with Modified Antisense Oligonucleotides. The Most Effective Target Sites Are Clustered in Double-Stranded Regions of the Predicted Secondary Structure for the mRNA ”, Biochemistry, vol. 33 (No. 38), pp. 11033-11039, 1994.
Donald M. Gray and Ignacio Tinoco, Jr., “A New Approach to the Study of Sequence-Dependent Properties of Polynucleotides,” Biopolymers, vol. 9, John Wiley & Sons, Inc., pp. 223-244, 1970.
Rosanne M. Orr and Brett P. Monia, “Antisense Therapy for Cancer”, Current Research in Molecular Therapeutics, vol. 1 (No. 2), pp. 102-108, 1998.
Soumitra Basu and Eric Wickstrom, “Temperature and Salt Dependence of Higher Order Structure Formation by Antisense c-myc and c-myb Phosphorothioate Oligodeoxyribonucleotides Containing T traguanylate Tracts”, Nucleic Acids Research, vol. 25 (No. 7), Oxford University Press, pp. 1327-1332, 1997.
Christian Beltinger, et al., “Binding, Uptake, and Intracellular Trafficking of Phosphorothioate-modified Oligodeoxynucleotides”, J. Clin. Invest., vol. 95, The American Society for Clinical Investigation, Inc. pp. 1814-1823, 1995.
C. Frank Bennett, et al., “Inhibition of Endothelial C II Adh slon Molecule Expression with Antisense Oligonucleotides”, Journal of Immunology, The American Association of Immunologists, pp. 3530-3540, 1994.
Philip Bernstein, Research Briefs, This Month in Nature Biotechnology, vol. 16 (No. 10), pp. 893-894, 1998.
Dwaine A. Braasch and David R. Corey, “Novel Antisense and Peptide Nucleic Acid Strategies for Controlling Gen Expression”, Biochemistry, vol. 41 (No. 14), The American Chemical Society, pp. 4503-4510, 2002.
Andrea D. Branch, “A Good Antisense Molecule Is Hard to Find”, Talking Point, Elsevier Science Ltd., pp. 45-50, 1998.
Catherine L. Cioffi, et al., “Selective Inhibition of A-Raf and C-Raf mRNA Expression by Antisense Oligodeoxynucleotides in Rat Vascular Smooth Muscle Cells: Role of A-Raf and C-Raf in Serum-Induced Proliferation”, Molecular Pharmacology, vol. 51, The American Society for Pharmacology and Experimental Therapeutics, pp. 383-389, 1997.
Nicholas M. Dean, et al., “Inhibition of Proetin Kinase C-α Expression in Human A549 Cells by Antisense Oligonucleotides Inhibits Induction of Intercellular Adhesion Molecule 1 (ICAM-1) mRNA by Phorbol Esters”, The Journal of Biological Chemistry, vol. 269 (No. 23), The American Society for Biochemistry and Molecular Biology, Inc., pp. 16416-16424, 1994.
Fritz Eckstein, “Searching For The Ideal Partner”, Nature Biotechnology, vol. 16, (No. 1) p. 24, 1998.
Fritz Eckstein, “Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?”, Antisense & Nucleic Acid Drug Development, vol. 10, Mary Ann Leibert, Inc., pp. 117-121, 2000.
R.V. Giles, et al., “Selecting Optimal Oligonucleotide Composition For Maximal Antisense Effect Following Streptoylsin O-Mediated Delivery into Human Leukaemia Cells”, Nucleic Acids Research, vol. 26, (No. 7), Oxford Univesitry Press, pp. 1567-1575, 1998.
Donald M. Gray, “Derivation of Nearest-Neighbor Properties from Data on Nucleic Acid Oligomers. I. Simple Sets of Independent Sequences and the Influence of Absent Nearest Neighbors”, Biopolymers, vol. 42, John Wiley & Sons, Inc., pp. 783-793, 1997.
Donald M. Gray, “Derivation of Nearest-Neighbor Properties From Data on Nucleic Acid Oligomers. II. Thermodynamic Parameters of DNA—RNA Hybrids and DNA Duplexes”, Biopolymers, vol. 42, John Wiley & Sons, Inc., pp. 795-810, 1997.
Gary D. Gray, et al., “Transformed and Immortalized Cellular Uptake of Oligodeoxynucleoside Phosphorothioates, 3′-Alkylamino Oligodeoxynucleoties, 2′-O-Methyl Oligoribonucleotides, Oligodeoxynucleoside Methlylphosphomates, and Peptide Nucleic Acids”, Biochemical Pharmacology, vol. 53, Elsevier Science, Inc., pp. 1465-1476, 1997.
Gihan M. Hasham, “Hybrid Oligomer Duplexes Formed With Phosphorothioate DNAs: CD Spectra and Melting Temperature of S-DNA-RNA Hybrids Are Sequence-Dependent but Consistent With Similar Heteronomous Conformations”, Biochemistry, vol. 37, American Chemical Society, pp. 61-72, 1998.
Siew Peng Ho, et al., “Potent Antisense Oligonucleotides to the Human Multidrug Resistance-1 mRNA ARe Rationally Selected by Mapping RNA-Accessible Sites With Oligonucleotide Libraries”, Nucleic Acids Research, vol. 24, (No. 10), Oxford University Press, pp. 1901-1907, 1996.
Siew Peng Ho, etal., “Mapping of RNA Accessibe Sites for Antisense Experiments With Oligonucleotide Libraries”, Nature Biotechnology, vol. 16, pp. 59-63, 1998.
Su-Hwi Hung, et al., “Evidence From CD Spectra That d(purine)-r(pyrimidine) and r(purine)—d(pyrimidine) Hybrids are in Different Structural Classes”, Nucleic Acids Research, vol. 22 (No. 20), Oxford Univers
Allen Marianne P.
Lin Jerry
Locke Liddell & Sapp
The Board of Regents University of Texas System
LandOfFree
Next-nearest-neighbor sequence determinants of antisense DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Next-nearest-neighbor sequence determinants of antisense DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Next-nearest-neighbor sequence determinants of antisense DNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3492545